Skip to main content
Acrivon Therapeutics, Inc. logo

Acrivon Therapeutics, Inc. — Investor Relations & Filings

Ticker · ACRV ISIN · US0048901096 US Manufacturing
Open in API
Filings indexed 293 across all filing types
Latest filing 2022-10-05 Regulatory Filings
Country US United States of America
Listing US ACRV

About Acrivon Therapeutics, Inc.

https://acrivon.com/

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company's core technology is its proprietary Acrivon Predictive Precision Proteomics (AP3) platform, which uses proteomics to identify the biologic drivers of cancer in individual patients. This platform enables the development of OncoSignature companion diagnostic tests designed to match patients with therapies predicted to be most effective for their specific tumor biology, a method distinct from genomic-based approaches. Acrivon's pipeline focuses on DNA Damage Response and cell cycle regulators. Its lead drug candidate, ACR-368 (prexasertib), is a selective kinase inhibitor in Phase 2 clinical trials for multiple solid tumor types. The pipeline also includes ACR-2316, a dual WEE1/PKMYT1 inhibitor. The company leverages its AP3 platform for internal drug development and for strategic co-development partnerships.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2022
Regulatory Filings
2022-10-05 English
Regulatory Filings 2022
Regulatory Filings Classification · 100% confidence The document is a detailed response letter from a company to the U.S. Securities and Exchange Commission (SEC) staff regarding comments on a Draft Registration Statement on Form S-1. The letter discusses revisions and clarifications to the company's registration statement, which is a filing used for securities offerings, typically an IPO or other public offering. The document references the Form S-1 multiple times and addresses SEC comments on disclosures, clinical trial stages, and pipeline information. It is not a financial report, earnings release, or management discussion, but rather a regulatory filing responding to SEC comments on a registration statement. Therefore, this document fits best under the category of Regulatory Filings (RNS), which includes general regulatory announcements and compliance documents that do not fit into other specific categories.
2022-09-22 English
Capital/Financing Update 2022
Capital/Financing Update Classification · 95% confidence The document is a confidential draft registration statement submitted to the SEC on Form S-1, which is used for initial public offerings (IPOs) to register securities under the Securities Act of 1933. It includes detailed information about the company, its business, management, risk factors, use of proceeds, and other disclosures typical of a registration statement for an IPO. This is not an annual report, earnings release, or any other type of financial report but a capital markets filing related to the company's offering of securities to the public. According to the filing definitions, updates on company fundraising or capital structure changes fall under Capital/Financing Update (CAP). Since this is a registration statement for an IPO, it is best classified as a Capital/Financing Update (CAP).
2022-09-22 English
Regulatory Filings 2022
Regulatory Filings
2022-09-15 English
Regulatory Filings 2022
Regulatory Filings
2022-09-12 English
Capital/Financing Update 2022
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement confidentially submitted to the SEC, which is used for initial public offerings (IPOs). It includes a preliminary prospectus with detailed information about the company, its business, management, risk factors, and financial data. The presence of underwriting details, offering price, and the statement that this is the company's initial public offering confirms this is a capital raising filing. Form S-1 is a registration statement for securities offerings under the Securities Act of 1933, which aligns with the Capital/Financing Update category. The document is not an annual report, earnings release, or any other report type but specifically a registration statement for a public offering.
2022-08-12 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.